Efficacy and safety of long-term treatment with low-dose rituximab for relapsing mixed cryoglobulinemia vasculitis.

about

Efficacy and safety of long-term treatment with low-dose rituximab for relapsing mixed cryoglobulinemia vasculitis.

Item

http://www.wikidata.org/entity/Q40362365

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Efficacy and safety of long-te ...... d cryoglobulinemia vasculitis.

@en

type

Item

label

Efficacy and safety of long-te ...... d cryoglobulinemia vasculitis.

@en

prefLabel

Efficacy and safety of long-te ...... d cryoglobulinemia vasculitis.

@en

P1476

Efficacy and safety of long-te ...... d cryoglobulinemia vasculitis.

@en

P2093

Baoran Yang

http://www.w3.org/2001/XMLSchema#string

Giuseppe M De Sanctis

http://www.w3.org/2001/XMLSchema#string

Julia Tola

http://www.w3.org/2001/XMLSchema#string

Marcella Visentini

http://www.w3.org/2001/XMLSchema#string

Massimo Fiorilli

http://www.w3.org/2001/XMLSchema#string

Maurizio Carlesimo

http://www.w3.org/2001/XMLSchema#string

Milica Mitrevski

http://www.w3.org/2001/XMLSchema#string

Milvia Casato

http://www.w3.org/2001/XMLSchema#string

Stefania Colantuono

http://www.w3.org/2001/XMLSchema#string

P2860

Cryoglobulins

Analysis of Hepatitis C Virus Hypervariable Region 1 Sequence from Cryoglobulinemic Patients and Associated Controls

Hepatitis C.

Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study.

Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry.

Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey.

Therapy for hepatitis C virus-related cryoglobulinemic vasculitis.

Genome-wide association study of hepatitis C virus- and cryoglobulin-related vasculitis.

Cryoglobulinemia Vasculitis.

A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis.

P304

617-623

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10067-017-3552-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28111716

http://www.w3.org/2001/XMLSchema#string